Purchases and Sales Made in Q2 2023 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q2 2023. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 07, 2023
Q2 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-52- 0.33% |
$158 - $468
|
15.7K
$144K
|
|
|
Aug 11, 2023
Q2 2023
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-67- 1.96% |
$203 - $603
|
3.36K
$30.8K
|
|
|
Aug 21, 2023
Q2 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-986- 10.17% |
$2.99K - $8.87K
|
8.71K
$79.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.16K- 29.93% |
$3.51K - $10.4K
|
2.72K
$24.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.92K- 2.14% |
$5.8K - $17.2K
|
87.4K
$802K
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2.33K- 52.17% |
$7.05K - $20.9K
|
2.13K
$19.6K
|
|
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-3.97K- 15.93% |
$12K - $35.7K
|
20.9K
$192K
|
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-5.52K- 19.74% |
$16.7K - $49.7K
|
22.5K
$206K
|
|
|
Aug 14, 2023
Q2 2023
|
Occudo Quantitative Strategies LP
Fort Lauderdale, FL |
SELL
|
- |
-21.2K- 58.46% |
$64.3K - $191K
|
15.1K
$138K
|
|
|
Aug 14, 2023
Q2 2023
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-25.8K- 10.95% |
$78.3K - $232K
|
210K
$1.93M
|
|
|
Aug 14, 2023
Q2 2023
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-48K- 10.0% |
$145K - $432K
|
432K
$3.96M
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-55.9K- 78.4% |
$169K - $503K
|
15.4K
$141K
|
|
|
Jul 31, 2023
Q2 2023
|
Levin Capital Strategies, L.P.
New York, NY |
SELL
|
- |
-58.5K- 74.05% |
$177K - $527K
|
20.5K
$188K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-70.3K- 7.65% |
$213K - $632K
|
848K
$7.77M
|
|
|
Oct 21, 2024
Q2 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-90.7K- 88.58% |
$275K - $816K
|
11.7K
$107K
|
|
|
Aug 14, 2023
Q2 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-111K- 22.71% |
$336K - $997K
|
377K
$3.46M
|
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-168K- 8.6% |
$508K - $1.51M
|
1.78M
$16.3M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-272K- 44.54% |
$825K - $2.45M
|
339K
$3.11M
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-276K- 39.22% |
$835K - $2.48M
|
427K
$3.92M
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-276K- 39.22% |
$835K - $2.48M
|
427K
$3.92M
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-328K- 98.07% |
$994K - $2.95M
|
6.47K
$59.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-714K- 12.35% |
$2.16M - $6.42M
|
5.06M
$46.4M
|